Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 24901-24950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06907810
Study of Lipid Mediators in Chronic Postoperative Pain - LICP
NARecruiting
300 participants
Started: Mar 12, 2025 · Completed: Mar 31, 2027
2 conditions2 sponsors1 location
NCT07126275
Mirror Journaling App Study
NAActive, not recruiting
500 participants
Started: Mar 12, 2025 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT07002762
Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
NARecruiting
100 participants
Started: Mar 12, 2025 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06839144
Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression
PHASE2Recruiting
60 participants
Started: Mar 12, 2025 · Completed: Aug 31, 2026
2 conditions3 sponsors2 locations
NCT06874192
Safety and Efficacy of LOw DOse COlchicine in Patients With STatin INTolerance: the LODOCO STINT Pilot Study
PHASE1Recruiting
30 participants
Started: Mar 12, 2025 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT06785818
Long-term Follow up Local Registry Study of Kymriah in South Korea
N/ARecruiting
500 participants
Started: Mar 12, 2025 · Completed: Dec 30, 2039
1 condition1 sponsor8 locations
NCT06582212
Enabling Women with Parkinson's Disease to Identify and Better Manage Hormonal Triggers of Parkinsonian Symptoms
NARecruiting
100 participants
Started: Mar 12, 2025 · Completed: Sep 12, 2027
5 conditions1 sponsor4 locations
NCT06815484
Preventing Burnout Among Caregivers Through Physical Activity
NARecruiting
86 participants
Started: Mar 12, 2025 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06714357
ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
PHASE2Recruiting
130 participants
Started: Mar 12, 2025 · Completed: Jun 20, 2027
1 condition1 sponsor5 locations
NCT06902311
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
PHASE2Recruiting
90 participants
Started: Mar 12, 2025 · Completed: Feb 29, 2028
4 conditions1 sponsor1 location
NCT06526585
Stress Management Program
NARecruiting
80 participants
Started: Mar 12, 2025 · Completed: Dec 30, 2026
2 conditions1 sponsor1 location
NCT06560905
Preoperative Planning With PSMA-PET in Melanoma Surgery Trial
PHASE2Recruiting
16 participants
Started: Mar 11, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06846515
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)
PHASE3Active, not recruiting
750 participants
Started: Mar 11, 2025 · Completed: Apr 30, 2026
4 conditions1 sponsor89 locations
NCT06917625
Follow up of Long Term Neurodevelopmental Impact of the Type of Feeding During the First Year of Life at 10 Years Old
N/AActive, not recruiting
5 participants
Started: Mar 11, 2025 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06961123
Establishment of a Longitudinal Cohort for Newborns With Low Apgar Scores at Birth
N/ARecruiting
600 participants
Started: Mar 11, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06840470
Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia
PHASE4Recruiting
40 participants
Started: Mar 11, 2025 · Completed: Sep 11, 2027
1 condition1 sponsor1 location
NCT06575686
Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
PHASE2Recruiting
33 participants
Started: Mar 11, 2025 · Completed: Jul 16, 2028
6 conditions2 sponsors2 locations
NCT07213232
Dual-Task Balance and Gait Training Combined With Cognitive Training in Parkinson's Patients
NAEnrolling by invitation
14 participants
Started: Mar 11, 2025 · Completed: Mar 3, 2026
4 conditions2 sponsors1 location
NCT06142825
Developing, Implementing and Evaluating Effective Community-facility Interactions to Improve Blood Availability and Transfusion in Three Distinct County Settings in Kenya
NAActive, not recruiting
9 participants
Started: Mar 11, 2025 · Completed: Jul 1, 2026
1 condition5 sponsors1 location
NCT06673329
Brodalumab in the Treatment of Immune-Related Adverse Events
PHASE1Recruiting
11 participants
Started: Mar 11, 2025 · Completed: Nov 30, 2026
18 conditions2 sponsors1 location
NCT07089511
Cord Blood Platelet Poor Plasma Eye Drops
NARecruiting
100 participants
Started: Mar 11, 2025 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06830980
Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH
NARecruiting
30 participants
Started: Mar 11, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor2 locations
NCT06738771
Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa
N/ARecruiting
600 participants
Started: Mar 11, 2025 · Completed: Jan 31, 2027
6 conditions1 sponsor48 locations
NCT06773910
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
PHASE2Recruiting
250 participants
Started: Mar 11, 2025 · Completed: Sep 30, 2032
1 condition2 sponsors23 locations
NCT06559332
Coronary Artery Disease Assessment Strategies in TAVI Patients
NARecruiting
546 participants
Started: Mar 11, 2025 · Completed: Mar 31, 2032
3 conditions3 sponsors1 location
NCT05973864
Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
PHASE2Recruiting
220 participants
Started: Mar 11, 2025 · Completed: Aug 31, 2028
1 condition1 sponsor8 locations
NCT06972264
Safety and Efficacy of VDPHL01 in Males With AGA
PHASE3Recruiting
480 participants
Started: Mar 11, 2025 · Completed: Nov 30, 2026
3 conditions1 sponsor41 locations
NCT06551038
Evaluating Primary Suicide Prevention in Adolescents With Risk Factors
NARecruiting
240 participants
Started: Mar 11, 2025 · Completed: Sep 30, 2028
1 condition1 sponsor10 locations
NCT06977113
Maternal High Fibre Fermented Diet Effect on Breastfed Infant Gut Microbiome
NARecruiting
56 participants
Started: Mar 11, 2025 · Completed: May 31, 2028
2 conditions1 sponsor1 location
NCT06911333
AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
36 participants
Started: Mar 11, 2025 · Completed: Feb 20, 2030
7 conditions1 sponsor3 locations
NCT07149233
Effectiveness of Inspiratory Muscle Training on Sleep in Patients With Obstructive Sleep Apnea
NAEnrolling by invitation
30 participants
Started: Mar 11, 2025 · Completed: Feb 20, 2026
2 conditions1 sponsor1 location
NCT06770673
Together Overcoming Diabetes - Great Plains
NARecruiting
80 participants
Started: Mar 11, 2025 · Completed: Dec 31, 2027
1 condition4 sponsors1 location
NCT07022223
Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma
PHASE2Recruiting
51 participants
Started: Mar 11, 2025 · Completed: Sep 11, 2029
1 condition18 sponsors18 locations
NCT06192160
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
PHASE2Recruiting
315 participants
Started: Mar 11, 2025 · Completed: Mar 11, 2027
1 condition2 sponsors27 locations
NCT06641466
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
PHASE3Recruiting
723 participants
Started: Mar 11, 2025 · Completed: Mar 30, 2027
1 condition1 sponsor66 locations
NCT06859567
Chester Step Test: is It Effective in Scleroderma Patients?
NANot yet recruiting
45 participants
Started: Mar 11, 2025 · Completed: Jul 15, 2025
3 conditions1 sponsor1 location
NCT06780267
Clinical Study of HRS-2129 for Postoperative Analgesia in Orthopaedics
PHASE1Recruiting
45 participants
Started: Mar 11, 2025 · Completed: Aug 30, 2025
1 condition1 sponsor1 location
NCT06524024
Clinical Study of Tumor Polypeptide DC-CTL in the Treatment of Solid Tumors
NANot yet recruiting
20 participants
Started: Mar 11, 2025 · Completed: Apr 1, 2026
1 condition1 sponsor0 locations
NCT06803485
Effect of Venlafaxine Versus Dosulepin in Pain Predominant Somatic Symptom Disorder
PHASE4Recruiting
84 participants
Started: Mar 11, 2025 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT06884189
Application of Plant Protection Products (PPP) in Apple Orchards
N/ARecruiting
16 participants
Started: Mar 11, 2025 · Completed: Dec 20, 2025
4 conditions3 sponsors1 location
NCT06940739
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
PHASE1/PHASE2Recruiting
42 participants
Started: Mar 11, 2025 · Completed: Jul 31, 2032
3 conditions1 sponsor2 locations
NCT06890572
Validation of the Efficacy of Air Purifiers in Indoor Environment and Allergic Symptoms in Allergic Rhinitis Patients
NARecruiting
44 participants
Started: Mar 11, 2025 · Completed: Jun 20, 2025
1 condition2 sponsors1 location
NCT06845176
Combining Motor Imagery and Tendon Vibration on the Effectiveness of Motor Imagery
NANot yet recruiting
33 participants
Started: Mar 11, 2025 · Completed: Mar 1, 2027
1 condition2 sponsors1 location
NCT06872983
Evaluation of the Use of Synthetic Glue for Mesh Fixation in Laparoscopic Sacrocolpopexy
NARecruiting
40 participants
Started: Mar 11, 2025 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT06830291
"Validation and Standardisation of a Neuralix Digital Ecological Battery"
N/ARecruiting
800 participants
Started: Mar 11, 2025 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06891508
The Placental Secretome as a Therapeutic Tool to Prevent Inflammation-induced Preterm Birth
NAActive, not recruiting
60 participants
Started: Mar 11, 2025 · Completed: Mar 20, 2028
1 condition1 sponsor1 location
NCT06883851
Effectiveness of Pelvic Floor Muscle Rehabilitation Combined With Desmopressin in Children With Primary Monosymptomatic Nocturnal Enuresis
NARecruiting
40 participants
Started: Mar 11, 2025 · Completed: Aug 30, 2027
2 conditions3 sponsors2 locations
NCT06849752
Early Assessment and Initiation of GuideLine-Directed Evidence-Based Management-HF
N/ARecruiting
1,000 participants
Started: Mar 11, 2025 · Completed: Dec 31, 2031
2 conditions4 sponsors1 location
NCT06687941
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
PHASE1Recruiting
70 participants
Started: Mar 11, 2025 · Completed: May 31, 2028
4 conditions5 sponsors4 locations
NCT06855173
Active External Rewarming from Accidental Hypothermia - a Dose-response Pilot Study
NAEnrolling by invitation
12 participants
Started: Mar 11, 2025 · Completed: Mar 12, 2025
1 condition1 sponsor1 location